House Health Committee advances broad package of health bills including stem cell, nursing oversight and workforce measures

Tennessee House Health Committee · March 31, 2026

Loading...

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The committee advanced a suite of health bills ranging from stem cell therapy guardrails to nursing education oversight, childcare funding pilots, licensure consolidation debate and multiple administrative cleanups; most passed by unanimous or near-unanimous votes.

The Tennessee House Health Committee moved a broad slate of health-related legislation, advancing multiple bills on a busy calendar.

Quick facts on bills the committee advanced: - HB 2101 (pseudoephedrine delivery): Passed 19-0; removes a vendor name reference and allows delivery with existing purchase limits and tracking. - HB 2246 (stem cell therapy): Passed 19-0 as amended; establishes guardrails including prohibitions on certain embryonic materials, cell viability reporting, storage safety standards and compliance with FDA/CLIA requirements. - HB 2398 (childcare workforce age change): Passed 19-0; lowers the minimum age to work in childcare centers from 18 to 16 to expand work-based learning and relieve staffing shortages. - HB 1369 (lead testing materials for WIC participants): Passed 17-0 with one present not voting; requires Departments of Health and Human Services to provide educational materials and resources for pregnant WIC recipients on blood lead testing and mitigation. - HB 2110 (Health Facilities Commission housekeeping): Passed 20-0 as amended; aligns procedures and authority and moves certain responsibilities to the Health Facilities Commission. - HB 2539 (CORE Act — licensure consolidation): Passed out of committee by recorded vote (18 ayes, 3 nays); generated extended debate and a departmental presentation on administrative structure and protections for licensure procedures.

Committee discussion ranged from technical clarifications to requests for later responses from the Department of Health on implementation details, third-party administrators, eligibility thresholds and funding sources. Several bills were sent to additional committees (Finance/Ways and Means; Calendar and Rules) for further consideration where appropriations or broader rule changes are implicated.

What’s next: Most advanced bills will proceed to subsequent committees for rule or fiscal review; sponsors and committee members requested follow-up briefings on implementation details such as administrative contracts and eligibility criteria where not specified on the floor.